Methods to potentiate intravenous estramustine phosphate
申请人:Kopreski Michael S.
公开号:US06849616B1
公开(公告)日:2005-02-01
Estramustine phosphate is an anti-mitotic chemotherapeutic drug with proven efficacy against cancer. The invention describes methods which potentiate the therapeutic benefit of intravenous estramustine phosphate. The invention provides for intravenous estramustine phosphate to be administered at a high dosage exceeding 1300 mg as a single dose. Efficacious enhancement of estramustine phosphate pharmacokinetics is thereby achieved. Further provided, estramustine phosphate may be intravenously administered for use in combinational regimens with other chemotherapeutic agent. The therapeutic advantages achieved using the intravenous estramustine phosphate formulation are applicable to treatment of a variety of cancers including prostate cancer, breast cancer, lung cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, and other cancers.
Potential Anticancer Agents. II. Urethan-Type Nitrogen Mustards of Some Natural Sex Hormones
作者:I. Niculescu-Duvaz、A. Cambanis、E. Tárnáuceanu
DOI:10.1021/jm00314a009
日期:1967.3
N-MUSTARD DERIVATIVES OF ESTROGENS
作者:Thomas Nogrady、Kitty M. Vagi、Vincent W. Adamkiewicz
DOI:10.1139/v62-326
日期:1962.11.1
N-Mustard urethanes of estrone and stilbestrol, as well as an N-mustard-phosphoramidate of stilbestrol, were synthesized. Only the estrone derivative proved to be slightly active against an adenocarcinoma.